Illumina upgraded to overweight at JPMorgan on clinical demand outlook
Go back to Illumina upgraded to overweight at JPMorgan on clinical demand outlook| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 165.45 +4.07 (2.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.38 | 52 Week High | $196.47 | |||
| Open | $161.80 | 52 Week Low | $127.10 | |||
| Day High | $165.74 | P/E | 183.83 | |||
| Day Low | $159.98 | EPS | $0.90 | |||
| Volume | 119,612 | |||||
